학술논문
Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized study
Document Type
Article
Author
GomezMancilla, Baltazar; Meriggioli, Matthew N.; Genge, Angela; Roubenoff, Ronenn; Espié, Pascal; Dupuy, Cyrielle; Hartmann, Nicole; Pezous, Nicole; Kinhikar, Arvind; Tichy, Mia; Dionne, Annie; Vissing, John; Andersen, Henning; Schoser, Benedikt; Meisel, Andreas; Jordan, Berit; Devlikamova, Farida; Poverennova, Irina; Stuchevskaya, Fatima; Lin, Thy-Sheng; Rush, James S.; Gergely, Peter
Source
In Journal of Clinical Neuroscience January 2024 119:76-84
Subject
Language
ISSN
0967-5868